Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis

Marganit Farago, Isabel Dominguez, Esther Landesman-Bollag, Xin Xu, Andrea Rosner, Robert Cardiff, David C. Seldin

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Recent studies have implicated ectopic activation of the Wnt pathway in many human cancers, including breast cancer, β-catenin is a critical coactivator in this signaling pathway and is regulated in a complex fashion by phosphorylation, degradation, and nuclear translocation. Glycogen synthase kinase 3β (GSK3β) phosphorylation of the NH2-terminal domain of β-catenin targets it for ubiquitination and proteosomal degradation. We hypothesized that expression of kinase-inactive GSK3β (KI-GSK3β) in mammary glands would function in a dominant-negative fashion by antagonizing the endogenous activity of GSK3β and promoting breast cancer development. Consistent with this, we find that KI-GSK3β stabilizes β-catenin expression, catalyzes its localization to the nucleus, and up-regulates the downstream target gene, cyclin D1, in vitro. In vivo, transgenic mice overexpressing the KI-GSK3β under the control of the mouse mammary tumor virus-long terminal repeat develop mammary tumors with overexpression of β-catenin and cyclin D1. Thus, antagonism of GSK3β activity is oncogenic in the mammary epithelium; mutation or pharmacologic down-regulation of GSK3β could promote mammary tumors.

Original languageEnglish (US)
Pages (from-to)5792-5801
Number of pages10
JournalCancer Research
Volume65
Issue number13
DOIs
StatePublished - Jul 1 2005

Fingerprint

Glycogen Synthase Kinase 3
Catenins
Carcinogenesis
Breast
Phosphotransferases
Breast Neoplasms
Phosphorylation
bcl-1 Genes
Mouse mammary tumor virus
Wnt Signaling Pathway
Terminal Repeat Sequences
Ubiquitination
Cyclin D1
Human Mammary Glands
Transgenic Mice
Up-Regulation
Down-Regulation
Epithelium
Mutation

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Farago, M., Dominguez, I., Landesman-Bollag, E., Xu, X., Rosner, A., Cardiff, R., & Seldin, D. C. (2005). Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. Cancer Research, 65(13), 5792-5801. https://doi.org/10.1158/0008-5472.CAN-05-1021

Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. / Farago, Marganit; Dominguez, Isabel; Landesman-Bollag, Esther; Xu, Xin; Rosner, Andrea; Cardiff, Robert; Seldin, David C.

In: Cancer Research, Vol. 65, No. 13, 01.07.2005, p. 5792-5801.

Research output: Contribution to journalArticle

Farago, M, Dominguez, I, Landesman-Bollag, E, Xu, X, Rosner, A, Cardiff, R & Seldin, DC 2005, 'Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis', Cancer Research, vol. 65, no. 13, pp. 5792-5801. https://doi.org/10.1158/0008-5472.CAN-05-1021
Farago, Marganit ; Dominguez, Isabel ; Landesman-Bollag, Esther ; Xu, Xin ; Rosner, Andrea ; Cardiff, Robert ; Seldin, David C. / Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis. In: Cancer Research. 2005 ; Vol. 65, No. 13. pp. 5792-5801.
@article{f120b99c31bc4581a1d26972f9346f23,
title = "Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis",
abstract = "Recent studies have implicated ectopic activation of the Wnt pathway in many human cancers, including breast cancer, β-catenin is a critical coactivator in this signaling pathway and is regulated in a complex fashion by phosphorylation, degradation, and nuclear translocation. Glycogen synthase kinase 3β (GSK3β) phosphorylation of the NH2-terminal domain of β-catenin targets it for ubiquitination and proteosomal degradation. We hypothesized that expression of kinase-inactive GSK3β (KI-GSK3β) in mammary glands would function in a dominant-negative fashion by antagonizing the endogenous activity of GSK3β and promoting breast cancer development. Consistent with this, we find that KI-GSK3β stabilizes β-catenin expression, catalyzes its localization to the nucleus, and up-regulates the downstream target gene, cyclin D1, in vitro. In vivo, transgenic mice overexpressing the KI-GSK3β under the control of the mouse mammary tumor virus-long terminal repeat develop mammary tumors with overexpression of β-catenin and cyclin D1. Thus, antagonism of GSK3β activity is oncogenic in the mammary epithelium; mutation or pharmacologic down-regulation of GSK3β could promote mammary tumors.",
author = "Marganit Farago and Isabel Dominguez and Esther Landesman-Bollag and Xin Xu and Andrea Rosner and Robert Cardiff and Seldin, {David C.}",
year = "2005",
month = "7",
day = "1",
doi = "10.1158/0008-5472.CAN-05-1021",
language = "English (US)",
volume = "65",
pages = "5792--5801",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis

AU - Farago, Marganit

AU - Dominguez, Isabel

AU - Landesman-Bollag, Esther

AU - Xu, Xin

AU - Rosner, Andrea

AU - Cardiff, Robert

AU - Seldin, David C.

PY - 2005/7/1

Y1 - 2005/7/1

N2 - Recent studies have implicated ectopic activation of the Wnt pathway in many human cancers, including breast cancer, β-catenin is a critical coactivator in this signaling pathway and is regulated in a complex fashion by phosphorylation, degradation, and nuclear translocation. Glycogen synthase kinase 3β (GSK3β) phosphorylation of the NH2-terminal domain of β-catenin targets it for ubiquitination and proteosomal degradation. We hypothesized that expression of kinase-inactive GSK3β (KI-GSK3β) in mammary glands would function in a dominant-negative fashion by antagonizing the endogenous activity of GSK3β and promoting breast cancer development. Consistent with this, we find that KI-GSK3β stabilizes β-catenin expression, catalyzes its localization to the nucleus, and up-regulates the downstream target gene, cyclin D1, in vitro. In vivo, transgenic mice overexpressing the KI-GSK3β under the control of the mouse mammary tumor virus-long terminal repeat develop mammary tumors with overexpression of β-catenin and cyclin D1. Thus, antagonism of GSK3β activity is oncogenic in the mammary epithelium; mutation or pharmacologic down-regulation of GSK3β could promote mammary tumors.

AB - Recent studies have implicated ectopic activation of the Wnt pathway in many human cancers, including breast cancer, β-catenin is a critical coactivator in this signaling pathway and is regulated in a complex fashion by phosphorylation, degradation, and nuclear translocation. Glycogen synthase kinase 3β (GSK3β) phosphorylation of the NH2-terminal domain of β-catenin targets it for ubiquitination and proteosomal degradation. We hypothesized that expression of kinase-inactive GSK3β (KI-GSK3β) in mammary glands would function in a dominant-negative fashion by antagonizing the endogenous activity of GSK3β and promoting breast cancer development. Consistent with this, we find that KI-GSK3β stabilizes β-catenin expression, catalyzes its localization to the nucleus, and up-regulates the downstream target gene, cyclin D1, in vitro. In vivo, transgenic mice overexpressing the KI-GSK3β under the control of the mouse mammary tumor virus-long terminal repeat develop mammary tumors with overexpression of β-catenin and cyclin D1. Thus, antagonism of GSK3β activity is oncogenic in the mammary epithelium; mutation or pharmacologic down-regulation of GSK3β could promote mammary tumors.

UR - http://www.scopus.com/inward/record.url?scp=21344463325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344463325&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-1021

DO - 10.1158/0008-5472.CAN-05-1021

M3 - Article

C2 - 15994955

AN - SCOPUS:21344463325

VL - 65

SP - 5792

EP - 5801

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 13

ER -